Palmitoylethanolamide (PEA) is an endogenous fatty acid amide produced naturally in the body in response to injury and stress. As one ages, the production of PEA decreases, which could allow for unbalanced levels of inflammation and a decreased immune system.
Gencor has developed a dispersible version of PEA, branded Levagen+, powered by Pharamako Biotechnologies LipiSperse delivery technology. This award-winning technology helps increase the bioavailability and functionality of PEA for use in beauty applications.
PEA is a powerful ingredient that can be applied in several health categories from beauty to sports nutrition
- R.V. Venkatesh, Co-founder at Gencor
Levagen+ helps target inflammaging, which refers to the chronic, low-grade inflammation associated with age-related changes in the skin. Common signs of this are uneven skin tone, dullness, fine lines, and dehydration. Upscale brands like LYMA Skincare have included Levagen+ in their breakthrough skincare line to improve elasticity, reduce redness, protect against oxidative stress-induced damage, and help slow the skin’s immunological dysregulation through the skin’s Extracellular Matrix (ECM).
“We refer to Levagen+ as the body’s natural defense system. PEA is a powerful ingredient that can be applied in several health categories from beauty to sports nutrition,” said R.V. Venkatesh, Co-founder at Gencor. “We are excited and humbled that cosmetic brands are utilizing Levagen+ for its ability to aid in a healthy inflammatory response, protect from oxidative stress and improve skin appearance.”
Levagen+ can be applied in several formats, including gels, creams, effervescents, powders, and more.
